Head and Neck Cancer (HNC) represents a diverse array of malignancies primarily categorized as squamous cell carcinomas, which originate from the epithelial mucosa within the upper aerodigestive tract. While targeted immunotherapy has notably enhanced survival outcomes for patients with HNS, the efficacy remains limited with fewer than 20% of patients achieving a long-lasting response. This underscores the urgent need for novel immunotherapeutic strategies that effectively engage all critical elements of the complex tumor microenvironment (TME) in HNC, aiming to bolster tumor-specific T cell responses. Furthermore, the field of Multi-Omics presents a comprehensive analytical approach that encompasses multiple "omics" layers, including genomics, proteomics, transcriptomics, epigenomics, metabolomics, and microbiomics. The evolution of omics technologies has revolutionized our ability to quantify and characterize the vast array of molecules like genes, mRNA, proteins, and metabolites, thus offering a detailed map of the intricate interactions and dynamics within the complex and varied biological systems of HNC.
In this research topic, we aim to address the critical need for better biomarkers that can predict therapeutic outcomes and guide immunotherapy decisions. Contributors are encouraged to present studies that contribute to a holistic view of the tumor immune environment, focusing on the discovery and validation of biomarkers that can predict response to treatment and aid in the development of more effective immunotherapeutic strategies.
This Research Topic accepts Original Research papers, Reviews, Mini-Reviews, Perspectives, Case Reports, and Brief Research Reports. We welcome manuscripts focusing on, but not limited to, the following sub-topics:
1. Advanced multi-omics techniques for profiling immunological landscapes in head and neck cancers.
2. Integration of genomic, proteomic, and metabolomic data to uncover novel immunotherapeutic targets and biomarkers.
3. Case studies and clinical trials that utilize multi-omics data to tailor immunotherapeutic approaches.
4. Cross-disciplinary analyses that bridge immunological research with clinical applications, focusing on the translational aspect of scientific discoveries.
5. Research that explores the underlying pathophysiological mechanisms of HNC through the lens of multi-omics and immunology.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.
Head and Neck Cancer (HNC) represents a diverse array of malignancies primarily categorized as squamous cell carcinomas, which originate from the epithelial mucosa within the upper aerodigestive tract. While targeted immunotherapy has notably enhanced survival outcomes for patients with HNS, the efficacy remains limited with fewer than 20% of patients achieving a long-lasting response. This underscores the urgent need for novel immunotherapeutic strategies that effectively engage all critical elements of the complex tumor microenvironment (TME) in HNC, aiming to bolster tumor-specific T cell responses. Furthermore, the field of Multi-Omics presents a comprehensive analytical approach that encompasses multiple "omics" layers, including genomics, proteomics, transcriptomics, epigenomics, metabolomics, and microbiomics. The evolution of omics technologies has revolutionized our ability to quantify and characterize the vast array of molecules like genes, mRNA, proteins, and metabolites, thus offering a detailed map of the intricate interactions and dynamics within the complex and varied biological systems of HNC.
In this research topic, we aim to address the critical need for better biomarkers that can predict therapeutic outcomes and guide immunotherapy decisions. Contributors are encouraged to present studies that contribute to a holistic view of the tumor immune environment, focusing on the discovery and validation of biomarkers that can predict response to treatment and aid in the development of more effective immunotherapeutic strategies.
This Research Topic accepts Original Research papers, Reviews, Mini-Reviews, Perspectives, Case Reports, and Brief Research Reports. We welcome manuscripts focusing on, but not limited to, the following sub-topics:
1. Advanced multi-omics techniques for profiling immunological landscapes in head and neck cancers.
2. Integration of genomic, proteomic, and metabolomic data to uncover novel immunotherapeutic targets and biomarkers.
3. Case studies and clinical trials that utilize multi-omics data to tailor immunotherapeutic approaches.
4. Cross-disciplinary analyses that bridge immunological research with clinical applications, focusing on the translational aspect of scientific discoveries.
5. Research that explores the underlying pathophysiological mechanisms of HNC through the lens of multi-omics and immunology.
Please note: manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of scope for this section and will not be accepted as part of this Research Topic.